Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection

轻症SARS-CoV-2感染中高细胞毒性CD8+ T细胞受体的募集

阅读:3
作者:Karolin I Wagner,Laura M Mateyka,Sebastian Jarosch,Vincent Grass,Simone Weber,Kilian Schober,Monika Hammel,Teresa Burrell,Behnam Kalali,Holger Poppert,Henriette Beyer,Sophia Schambeck,Stefan Holdenrieder,Andrea Strötges-Achatz,Verena Haselmann,Michael Neumaier,Johanna Erber,Alina Priller,Sarah Yazici,Hedwig Roggendorf,Marcus Odendahl,Torsten Tonn,Andrea Dick,Klaus Witter,Hrvoje Mijočević,Ulrike Protzer,Percy A Knolle,Andreas Pichlmair,Claudia S Crowell,Markus Gerhard,Elvira D'Ippolito,Dirk H Busch

Abstract

T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and has been studied widely on a quantitative level. However, the quality of responses, in particular of CD8+ T cells, has only been investigated marginally so far. Here, we isolate T cell receptor (TCR) repertoires specific for immunodominant SARS-CoV-2 epitopes restricted to common human Leukocyte antigen (HLA) class I molecules in convalescent individuals. SARS-CoV-2-specific CD8+ T cells are detected up to 12 months after infection. TCR repertoires are diverse, with heterogeneous functional avidity and cytotoxicity toward virus-infected cells, as demonstrated for TCR-engineered T cells. High TCR functionality correlates with gene signatures that, remarkably, could be retrieved for each epitope:HLA combination analyzed. Overall, our data demonstrate that polyclonal and highly functional CD8+ TCRs-classic features of protective immunity-are recruited upon mild SARS-CoV-2 infection, providing tools to assess the quality of and potentially restore functional CD8+ T cell immunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。